Trial Profile
Phase I trial of stem cell therapy (Megadose Drug Combination) for the prevention of mismatched bone marrow transplant rejection
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2015
Price :
$35
*
At a glance
- Drugs Megadose drug combination Cell Source (Primary)
- Indications Bone marrow transplant rejection
- Focus Adverse reactions
- 13 Jul 2015 New trial record